ConductScience.org, home

Trial · NCT07886814

Registered outcomes11

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryIncidence of Dysuria on Postoperative Day 1Postoperative Day 1 (within 24 hours after surgery)
The primary outcome was the incidence of postoperative dysuria, defined as patient-reported pain, burning, or discomfort during urination within the first 24 hours following laparoscopic total extraperitoneal inguinal hernia repair. Dysuria was assessed as a binary outcome (present or absent). The proportion of participants experiencing dysuria was compared between the urinary catheterization and no-catheterization groups.
SecondaryIncidence of Urinary or Urethral Pain on Postoperative Day 1Postoperative Day 1 (within 24 hours after surgery)
The presence of urinary or urethral pain was assessed on postoperative day 1 using a visual analog scale (VAS) ranging from 0 (no pain) to 10 (worst imaginable pain). Pain was considered present when the VAS score was greater than 0. The proportion of participants reporting pain was compared between the two study groups.
SecondaryIncidence of Urinary or Urethral Pain on Postoperative Day 10Postoperative Day 10
Urinary or urethral pain was assessed on postoperative day 10 using a 0-10 visual analog scale (VAS). Pain was classified as present when the VAS score was greater than 0. The incidence of pain was compared between the urinary catheterization and no-catheterization groups.
SecondaryIncidence of Urinary or Urethral Pain on Postoperative Day 30Postoperative Day 30
Urinary or urethral pain was assessed on postoperative day 30 using a visual analog scale (VAS) ranging from 0 to 10. Pain was defined as a VAS score greater than 0. The proportion of participants reporting pain was evaluated in each intervention group.
SecondaryUrinary or Urethral Pain Severity on Postoperative Day 1Postoperative Day 1
The severity of urinary or urethral pain was assessed using an 11-point visual analog scale (VAS), ranging from 0 (no pain) to 10 (worst imaginable pain). Pain scores were compared between the urinary catheterization and no-catheterization groups.
SecondaryUrinary or Urethral Pain Severity on Postoperative Day 10Postoperative Day 10Urinary or urethral pain intensity was measured using a 0-10 visual analog scale (VAS) on postoperative day 10. Higher scores indicated greater pain intensity.
SecondaryUrinary or Urethral Pain Severity on Postoperative Day 30Postoperative Day 30Urinary or urethral pain intensity was evaluated on postoperative day 30 using a visual analog scale (VAS) ranging from 0 (no pain) to 10 (worst imaginable pain).
SecondaryIncidence of Urinary or Urethral Pain During the First 30 Postoperative DaysPostoperative Days 1, 10, and 30
The composite incidence of postoperative urinary or urethral pain was defined as the presence of pain (VAS score greater than 0) at any of the scheduled postoperative assessments on days 1, 10, or 30. Participants reporting pain at least once during the follow-up period were classified as having experienced urinary or urethral pain. The proportion of affected participants was compared between the two groups.
SecondaryIncidence of Postoperative Urinary RetentionWithin 30 days after surgery
Postoperative urinary retention was assessed during postoperative follow-up. The incidence of urinary retention was recorded as a binary outcome (present or absent), and the proportion of affected participants was compared between the urinary catheterization and no-catheterization groups.
SecondaryIncidence of Postoperative ComplicationsWithin 30 days after surgery
Postoperative complications were assessed during the first 30 days after laparoscopic TEP inguinal hernia repair. Recorded complications included urinary retention, scrotal emphysema, and scrotal ecchymosis. The proportion of participants experiencing at least one postoperative complication was compared between the intervention groups.
SecondaryIncidence of Inguinal Hernia Recurrence Within Six MonthsUp to 6 months after surgery
Hernia recurrence was assessed during a six-month postoperative follow-up period. Recurrence was defined as the reappearance of an inguinal hernia following laparoscopic TEP repair, as identified through postoperative clinical evaluation. The proportion of participants experiencing recurrence was compared between the two intervention groups.

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT07886814/registered